Skip to content

MEDICE

Active
Private limited companyfounded 200916 yrs activeHeirbaan 16, 3110 Rotselaar, BelgiumKBO/BCE: BE 0821.885.255

MEDICE has been active since 2009 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €936k and a net result of €200k. Equity is growing by ~19.5% per year across the filed fiscal years. Its solvency ranks better than 64% of 2295 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Checked score

Score 2025
100 / 100
Excellent= vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency100=
Growth78=
Stability100
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €95k at 30 days acceptable
Liquidity ample (current ratio 3.85 against 2.77 in 2024), and 24.8% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
lowers riskneutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
75.2%
Return on assets
16.1%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 16 years 0 20 y
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 13-07-2026, 18 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
18 d early
2024
23 d early
2023
5 d early
2022
18 d early
2021
34 d early
2020
3 d early
2019
11 d late
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
16-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, abbreviated schema

Equity
€936k▲ 27.2%
2024 · €736k
2018: €196k 2019: €238k 2020: €401k 2021: €444k 2022: €601k 2023: €676k 2024: €736k
2018 → 2025
Total assets
€1.24M▲ 13.0%
2024 · €1.10M
2018: €521k 2019: €528k 2020: €694k 2021: €725k 2022: €896k 2023: €931k 2024: €1.10M
2018 → 2025
Net result
€200k▲ 5.7%
2024 · €189k
2018: €55k 2019: €132k 2020: €163k 2021: €100k 2022: €157k 2023: €75k 2024: €189k
2018 → 2025
Working capital
€692k▲ 44.4%
2024 · €479k
2018: €138k 2019: €20k 2020: €176k 2021: €220k 2022: €387k 2023: €403k 2024: €479k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€444k-€601k▲ 35.3%€676k▲ 12.5%€736k▲ 8.8%€936k▲ 27.2%
Operating result€150k-€231k▲ 54.5%€110k▼ 52.5%€275k▲ 151%€296k▲ 7.4%
Net result€100k-€157k▲ 57.0%€75k▼ 52.0%€189k▲ 151%€200k▲ 5.7%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
€0€100k€200k€300kOperating result 2021: €150k€150kNet result 2021: €100k€100kOperating result 2022: €231k€231kNet result 2022: €157k€157kOperating result 2023: €110k€110kNet result 2023: €75k€75kOperating result 2024: €275k€275kNet result 2024: €189k€189kOperating result 2025: €296k€296kNet result 2025: €200k€200k20212022202320242025
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 7% above 2024 and is the highest year so far.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.24M
Fixed assets €310k▼ 11.6%
Current assets €934k▲ 24.6%
Equity and liabilities €1.24M
Equity €936k▲ 27.2%
Debt €309k▼ 15.5%
The debt ratio falls from 33.2% to 24.8%: equity grows while debt is paid down.
Key figures and ratios
2025 value · change against 2024
EBITDA
€339k
2024 · €318k
Cash flow
€244k
2024 · €232k
Solvency
75.2%
2024 · 66.8%
Current ratio
3.85
2024 · 2.77
Quick ratio
3.85
2024 · 2.77
Debt / equity
0.33
2024 · 0.50
ROE
21.4%
2024 · 25.7%
ROA
16.1%
2024 · 17.2%
Interest coverage
139.75
2024 · 115.26
Debt
€309k
2024 · €365k
Debt ≤ 1 year
€243k
2024 · €271k
Debt > 1 year
€66k
2024 · €81k
Income taxes
€94k
2024 · €91k
Staff costs
€245k
2024 · €209k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€1.10M€1.24M
Fixed assets21/28€351k€310k
Tangible fixed assets22/27€351k€310k
Land and buildings22€280k€258k
Plant, machinery and equipment23€4k€5k
Furniture and vehicles24€53k€37k
Other tangible fixed assets26€14k€10k
Current assets29/58€750k€934k
Amounts receivable after more than one year29€180k€240k
Other amounts receivable291€180k€240k
Amounts receivable within one year40/41€138k€126k
Trade receivables40€103k€126k
Other amounts receivable41€35k€0
Current investments50/53€0-
Cash at bank and in hand54/58€430k€566k
Deferred charges and accrued income490/1€2k€2k
Equity and liabilities
Total equity and liabilities10/49€1.10M€1.24M
Equity10/15€736k€936k
Contributions10/11€19k€19k=
Reserves13€717k€917k
Non-distributable reserves130/1€11k€11k=
Reserves not available under the articles1311€11k€11k=
Distributable reserves133€706k€906k
Profit (loss) carried forward14€0€0=
Amounts payable17/49€365k€309k
Amounts payable after more than one year17€81k€66k
Financial debts170/4€81k€66k
Amounts payable within one year42/48€271k€243k
Current portion of amounts payable after more than one year42€15k€15k
Trade debts44€8k€39k
Suppliers440/4€8k€39k
Taxes, remuneration and social security45€125k€185k
Taxes450/3€76k€118k
Remuneration and social security454/9€49k€67k
Other amounts payable47/48€124k€3k
Accrued charges and deferred income492/3€13k€0
Income statement Code20242025
Non-recurring operating income76A€0-
Remuneration, social security and pensions62€209k€245k
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€43k€44k
Other operating charges640/8€5k€3k
Gross operating margin9900€532k€588k
Operating profit (loss)9901€275k€296k
Financial income75/76B€8k€1k
Recurring financial income75€8k€1k
Financial charges65/66B€3k€2k
Recurring financial charges65€3k€2k
Profit (loss) for the period before taxes9903€280k€294k
Income taxes67/77€91k€94k
Profit (loss) for the period9904€189k€200k
Profit (loss) for the period to be appropriated9905€189k€200k
Appropriation of the result
Profit (loss) to be appropriated9906€189k€200k
Transfer from equity791/2€130k€0
Transfer to equity691/2€189k€200k
To other reserves6921€189k€200k
Profit to be distributed694/7€130k€0
Return on contributions (dividend)694€130k€0
Social balance
Average headcount (FTE)90874.34.9

The notes to these accounts (12 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
13-07
NBB filing Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
31-12
Financial Highest result since 2018net €200k ▲5.7%
Operating result €296k, net result €200k, both a record.
08-07
NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
26-07
NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
13-07
NBB filing Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
31-12
Financial Equity above €500kEq €601k ▲35.3%
5 profitable years in a row build equity to €601k.
27-06
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
28-07
NBB filing Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
11-08
NBB filing Annual accounts filed
fiscal year 2019 · abbreviated schema · 11 days late
2019
31-12
Financial Equity above €200kEq €238k ▲21.5%
2 profitable years in a row build equity to €238k.
21-06
NBB filing Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
19-06
NBB filing Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
20-06
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
5 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Rotselaar · 1 establishment unit since 2010
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Heirbaan 163110 Rotselaar
Ground area
2,433 m²
Building footprint
315 m²
Volume, LiDAR
2,185 m³
Parcel 24094E0093/00D000, Flanders · tallest building 10.6 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
MEDICE
Heirbaan 16, 3110 RotselaarGeneral medical practice
since 20102.185.011.706
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
24094E0093/00D000 Flanders 2,433 m² 1 · 315 m² 10.6 m · 2 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Public money · subsidies and aid

Flemish government

2025 · 1 entry · 240 EUR awarded · 240 EUR paid
Year Entries awardedpaid
2025 1 240 EUR240 EUR
Schemes
Subsidie voor opleiding en advies voor kmo's en zelfstandigen (kmo-portefeuille)
1 entry · 240 EUR · 240 EUR paid · Fonds voor Innoveren en Ondernemen

Similar companies · same sector, comparable size

Of 9,102 companies in sector 86210 we hold annual accounts for 6,323. 4,155 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded30-12-2009
Fiscal year end31-12
Activities, NACEBEL
86210General medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 16 filingsAddress and cadastre registers

Data from official sources, last processed on 15-09-2026. Scores and ratios are computed by Checked and are not a credit decision.